«Androgenetic alopecia: an evidence-based treatment update». American Journal of Clinical Dermatology15 (3): 217–30. July 2014. doi:10.1007/s40257-014-0077-5. PMID24848508.
«Alopecia areata: an evidence-based treatment update». American Journal of Clinical Dermatology15 (3): 231–46. July 2014. doi:10.1007/s40257-014-0086-4. PMID25000998.
Wambier, Carlos Gustavo; Craiglow, Brittany G.; King, Brett A. (2020). «Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK». Surgical & Cosmetic Dermatology12 (1). doi:10.5935/scd1984-8773.20201211512.
Wambier, Carlos G.; Craiglow, Brittany G.; King, Brett A. (September 2021). «Combination tofacitinib and oral minoxidil treatment for severe alopecia areata». Journal of the American Academy of Dermatology85 (3): 743–745. doi:10.1016/j.jaad.2019.08.080. PMID31499158.
«Pseudoacromegaly induced by the long-term use of minoxidil». Journal of the American Academy of Dermatology48 (6): 962–5. June 2003. doi:10.1067/mjd.2003.325. PMID12789195.
«Hypertrichosis in females applying minoxidil topical solution and in normal controls». Journal of the European Academy of Dermatology and Venereology17 (3): 271–5. May 2003. doi:10.1046/j.1468-3083.2003.00621.x. PMID12702063.
«Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway». Neuropharmacology75: 407–15. December 2013. doi:10.1016/j.neuropharm.2013.08.004. PMID23973310.
«Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade». The New England Journal of Medicine282 (10): 521–7. March 1970. doi:10.1056/NEJM197003052821001. PMID4391708.
«Suspected toxicosis after topical administration of minoxidil in 2 cats». Journal of Veterinary Emergency and Critical Care14 (4): 287–292. November 2004. doi:10.1111/j.1476-4431.2004.04014.x.
«Androgenetic alopecia: an evidence-based treatment update». American Journal of Clinical Dermatology15 (3): 217–30. July 2014. doi:10.1007/s40257-014-0077-5. PMID24848508.
«Alopecia areata: an evidence-based treatment update». American Journal of Clinical Dermatology15 (3): 231–46. July 2014. doi:10.1007/s40257-014-0086-4. PMID25000998.
Wambier, Carlos G.; Craiglow, Brittany G.; King, Brett A. (September 2021). «Combination tofacitinib and oral minoxidil treatment for severe alopecia areata». Journal of the American Academy of Dermatology85 (3): 743–745. doi:10.1016/j.jaad.2019.08.080. PMID31499158.
«Pseudoacromegaly induced by the long-term use of minoxidil». Journal of the American Academy of Dermatology48 (6): 962–5. June 2003. doi:10.1067/mjd.2003.325. PMID12789195.
«Hypertrichosis in females applying minoxidil topical solution and in normal controls». Journal of the European Academy of Dermatology and Venereology17 (3): 271–5. May 2003. doi:10.1046/j.1468-3083.2003.00621.x. PMID12702063.
«Interactions of minoxidil with vasoconstrictive agents in isolated rat tail artery». Acta Poloniae Pharmaceutica52 (3): 253–6. May 1995. PMID8960256.
«Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway». Neuropharmacology75: 407–15. December 2013. doi:10.1016/j.neuropharm.2013.08.004. PMID23973310.
«Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade». The New England Journal of Medicine282 (10): 521–7. March 1970. doi:10.1056/NEJM197003052821001. PMID4391708.